Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Revamped CDRH Science Office Reaching Out To Industry, Other Agencies

This article was originally published in The Gray Sheet

  • News

Executive Summary

CDRH's Office of Science & Technology is exploring ways to include industry representatives in device research project selection

You may also be interested in...



CDRH Science Office Will Team With Industry On Internal Research Agenda

CDRH's Office of Science & Engineering Laboratories will consult with industry and academia experts in a fall evaluation of device research projects, according to Director Larry Kessler

CDRH Science Office Will Team With Industry On Internal Research Agenda

CDRH's Office of Science & Engineering Laboratories will consult with industry and academia experts in a fall evaluation of device research projects, according to Director Larry Kessler

CDRH Science Office Reorganization Eliminates Branches, Focuses On Labs

The device center's Office of Science & Technology is set to unveil organizational changes, following efforts to revamp the office based on internal and external program reviews

Table

View full table

Tags:
Latest Headlines

Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease

Small Sterilization Companies Poised To Meet EtO Emissions Goals On Time

At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use

UK MHRA Updates Assistive Tech And Borderline Regulations

See All
UsernamePublicRestriction

Register

MT019728

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By